About Index Trending news
Analyze
Top 50 Pricing
TxCell

TxCell

TxCell

TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.

Elsewhere

Alexa global traffic share

14 Apr 2014
$21,361,708
Venture capital
26 Nov 2012
$16,075,360
Venture capital (Series C)
01 Feb 2008
$19,743,385
Venture capital (Series B)
01 Oct 2004
$13,002,827
Venture capital (Series A)